Company Data
Trevena Inc.
Ticker
TRVN
Current Price
$1.08 4.85%
Market Cap
$11.8M
Price Target
Refer to Report
Volume
426.3K
52wk Range
$0.58 - $12.22
Overview
Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.
Other Considerations
Company
Ticker
Price
Previous
Mkt Cap
Volume
52wk Range
